BRAF and thyroid cancer: To date, the most common alteration in thyroid cancer is BRAF gene mutation, which most often occurs in papillary (40–45%) and poorly differentiated cancers (20–40%) and whose prevalence in indeterminate lesions varies between 15% and 40% [33, 42–44].